ONT: Clinical and biopharma growth, margin gains, and strategic focus drive positive outlook to 2027
Strong device sales and margin improvements offset regional headwinds, with clinical and biopharma segments driving growth. Strategic focus has shifted to high-value applications, operational discipline, and leveraging AI and software for future expansion. Margin expansion and EBITDA breakeven by 2…